Ads
related to: tailor made compounding peptide catalog companies free
Search results
Results from the WOW.Com Content Network
Pharmaceutical compounding - the creation and dispensing of tailor-made medications - is the root of the pharmacy profession, often symbolised by the mortar and pestle. Compounding allows the pharmacist to work with the patient and the prescriber to customise medication to meet the patient’s specific needs.
In 1993, Bio-Synthesis was one of the first peptide synthesis companies to acquire a Finnigan MALDI-TOF mass spectrometer for the accurate quality control of synthetic peptides produced in-house. In 1994, Bio-synthesis pioneered the use of molecular methods for HLA analysis which is applied in organ matching for transplantation purposes.
CPC Scientific has published some research articles that describe peptide synthesis methodologies, [3] [4] including a technique called hydrocarbon stapling. [ 5 ] [ 6 ] Stapled peptides contain a synthetic modification that involves olefin metathesis to stabilize alpha-helix and beta-sheet secondary structures.
Eli Lilly on Thursday said it sued 11 online pharmacies to stop them from importing, selling and distributing products claiming to contain the active ingredient in its diabetes drug Mounjaro ...
For premium support please call: 800-290-4726 more ways to reach us
Due to the rising cost of compounding and drug shortages, some hospitals outsource their compounding needs to large-scale compounding pharmacies, particularly of sterile-injectable medications. Compounding preparations of a given formulation in advance batches, as opposed to preparation for a specific patient on demand, is known as "non ...
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. [1] The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. [2] In 2018, they opened a subsidiary in the US. [3]
At its R&D day in October 2010, BioMarin also announced a new program for a peptide therapeutic, vosoritide (BMN-111), for the treatment of achondroplasia. [ 14 ] In 2012, BioMarin acquired Zacharon Pharmaceuticals, a private biotechnology company based in San Diego focused on developing small molecules targeting pathways of glycan metabolism.
Ads
related to: tailor made compounding peptide catalog companies free